NASDAQ:JSPR

Jasper Therapeutics Stock Predictions

etoro logo Buy JSPR
*Your capital is at risk
$0.532
-0.0190 (-3.45%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

JSPR Prediction Chart

JSPR Predictions History

Latest community submissions for JSPR.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 14, 2025 Bullish $4.20 V 1
Mar 10, 2025 Bearish $5.28 V 1
Feb 13, 2025 $5.87 +6.99% $6.20 V 94.74% 1
Feb 13, 2025 $5.73 +4.37% $6.20 V 92.42% 1
Feb 13, 2025 Bullish $6.20 V 1
Feb 11, 2025 $6.37 +6.57% $5.38 X 81.54% 0
Feb 11, 2025 $6.23 +4.11% $5.38 X 84.28% 0
Feb 11, 2025 Bullish $5.38 X 0
Apr 11, 2024 $28.77 +2.98% $29.08 V 98.94% 2
Apr 11, 2024 $27.42 -1.86% $29.08 X 94.29% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for JSPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT JASPER THERAPEUTICS, INC.
Jasper Therapeutics
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The co...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE